Cargando…

The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes

IgA nephropathy (IgAN) is a rather uncommon complication of TNF-alpha inhibition with a range of findings such as asymptomatic microscopic/macroscopic hematuria or different degrees of proteinuria and could progress to end-stage renal disease. We are reporting three patients with longstanding rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Premužić, Vedran, Padjen, Ivan, Cerovec, Mislav, Ćorić, Marijana, Jelaković, Bojan, Anić, Branimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191367/ https://www.ncbi.nlm.nih.gov/pubmed/32373375 http://dx.doi.org/10.1155/2020/9480860

Ejemplares similares

Corrigendum to “The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes”
por: Premužić, Vedran, et al.
Publicado: (2020)

Prevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia
por: Cerovec, Mislav, et al.
Publicado: (2012)

Acute Kidney Failure as a Single Complication of Varicella Virus Infection in an Adult Patient
por: Premužić, Vedran, et al.
Publicado: (2018)

Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period
por: Padjen, Ivan, et al.
Publicado: (2018)

White coat hypertension is another clinical characteristic of patients with inflammatory bowel disease: A cross-sectional study
por: Premužić, Vedran, et al.
Publicado: (2022)

Different circadian patterns of arterial stiffness are responsible for increased cardiovascular mortality in hemodialyzed patients
por: Premužić, Vedran, et al.
Publicado: (2021)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
por: Padjen, Ivan, et al.
Publicado: (2020)

Renal abnormalities in rheumatoid arthritis: an insight on IgA nephropathy
por: Prata, Ana R, et al.
Publicado: (2021)

Adiponectin is Not Associated With Blood Pressure in Normotensives and Untreated Hypertensives With Normal Kidney Function
por: Ivković, Vanja, et al.
Publicado: (2014)

Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis
por: Premuzic, Vedran, et al.
Publicado: (2020)

OSTIAL VERSUS TRUNCAL RENAL ARTERY STENOSIS: PREDICTOR OF LARGE ARTERY ATHEROSCLEROSIS SEVERITY AND HIGHER MORTALITY
por: Perkov, Dražen, et al.
Publicado: (2019)

Reliability of CKD-EPI predictive equation in estimating chronic kidney disease prevalence in the Croatian endemic nephropathy area
por: Fuček, Mirjana, et al.
Publicado: (2017)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

A Rare Case of Superior Vena Cava Syndrome in a Patient With Rheumatoid Arthritis and IgA Nephropathy
por: Moore, Colton M, et al.
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation: European Society of Hypertension project – ESH A Fib
por: Premužić, Vedran, et al.
Publicado: (2021)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

Tuberculosis-associated IgA nephropathy
por: Wang, Yamei, et al.
Publicado: (2018)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Spondyloarthritis-Associated IgA Nephropathy
por: Champtiaux, Nicolas, et al.
Publicado: (2020)

Immunological Pattern in IgA Nephropathy
por: Esteve Cols, Clara, et al.
Publicado: (2020)

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

Erythrocytosis associated with IgA nephropathy
por: Cohen, Camille, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eglcbs0sa902id32mo877idh4p